Nurix Therapeutics Inc [NRIX]
Données pivot
Statistiques pivot
| Métrique | Moyenne | Médiane | Écart type |
|---|---|---|---|
| Gain % | 18.21% | 18.21% | 2.36% |
| Perte % | -17.57% | -17.57% | 0.00% |
| Durée | 10.0d | 10d | 3.0d |
| Total des pivots trouvés | 4 |
| Segments gain/perte | 3 (2 Gain / 1 Perte) |
| Dernier pivot | Top @ $17.55 le 2026-06-18 |
| Variation depuis le dernier pivot | $0.00 (0.00%) |
Prévision du prochain pivot Dernier : $0.00
| Prochain type prévu | Bottom |
| Prix prévu (moy.) | $14.47 |
| Prix prévu (médiane) | $14.47 |
| Fourchette de prix prévue (~68%) | $14.47 - $14.47 |
| Variation vers cible moyenne | $14.47 (N/A) |
| Date prévue (moy.) | 2026-06-28 |
| Plage de dates prévue (~68%) | 2026-06-25 - 2026-07-01 |
| Base | Based on 1 historical losses (Avg: -17.57%, Median: -17.57%, StdDev of Abs: 0.00%) and duration (Avg: 10.0 days, StdDev: 3.0 days) |
| Note | Ranges assume ~normal distribution & historical patterns repeat. Use with caution. |
Moderate gain for Nurix Therapeutics Incon Thursday .
Nurix Therapeutics Inc (NRIX) stock price delivered a strong performance on Thursday after the stock rose $0.430 (2.51%) from the previous session on normal volume. The stock slightly outperformed the market today, moving slightly ahead of the NASDAQ's 1.91% rise.(The stock has risen 3 days straight. This extended rally increases the chances of a price pullback soon) A total of 4.25M stocks were traded yesterday, valued at $74.60M, 1.74M shares more than the previous day (2 514 280 shares traded). This is near the average volume for the stock at 4.79M shares traded per day.
Nurix Therapeutics Inc signals
There is no conclusive signals given from RSI. The price is above both the short- and long-term averages, and the short-term average is above the long-term average, confirming an established up-trend. Strong Bullish Consensus: A powerful wave of positive momentum is evident across all timeframes. Technical indicators are decisively bullish in the short-term (17/30, net +53.3%), medium-term (17/30, net +53.3%), and long-term (17/30, net +53.3%), signaling a robust and sustained uptrend.
Nurix Therapeutics Inc Support & Resistance Levels
The stock is trading above the closest support level at $17.00. approximately $0.550 (3.13%) away. This suggests it is currently acting as a floor, approaching it.The sup dis das support s117 -
Nurix Therapeutics Inc Evaluation
- Court score: 4.90
- Moyen score: 5.88
- Long score: 5.56